Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
about
Functional correction of dystrophin actin binding domain mutations by genome editing.Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy.ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.A dystrophic Duchenne mouse model for testing human antisense oligonucleotides.
P2860
Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Creation of a Novel Humanized ...... SPR/Cas9 Gene Editing Therapy.
@en
type
label
Creation of a Novel Humanized ...... SPR/Cas9 Gene Editing Therapy.
@en
prefLabel
Creation of a Novel Humanized ...... SPR/Cas9 Gene Editing Therapy.
@en
P2093
P2860
P356
P1476
Creation of a Novel Humanized ...... SPR/Cas9 Gene Editing Therapy.
@en
P2093
April D Pyle
Courtney S Young
Ekaterina Mokhonova
Marbella Quinonez
Melissa J Spencer
P2860
P304
P356
10.3233/JND-170218
P577
2017-05-06T00:00:00Z